Degradation effect of diepoxide fixation on porcine endogenous retrovirus DNA in heart valves: Molecular aspects

International Journal of Artificial Organs

Volumn 35, Issue 1, 2012, Pages 25-33

  Cyganek Niemiec, Aleksandra ^a   Strzalka Mrozik, Barbara ^b   Pawlus Lachecka, Lucyna ^a   Wszolek, Jolanta ^a   Adamska, Jolanta ^b   Kudrjavtseva, Julia ^c   Zhuravleva, Irina ^c   Kimsa, Malgorzata ^b   Okla, Hubert ^b   Kimsa, Magdalena ^b   Gudek, Agnieszka ^b   Mazurek, Urszula ^b  

^a Fundacja Rozwoju Kardiochirurgii Zabrze   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c Scientific Institute of Cardiovascular Diseases of SB RAMS   (Russian Federation)

Author keywords

Ethylene glycol diglycidyl ether; Glutaraldehyde; Porcine endogenous retroviruses; Porcine heart valves; Real time PCR

Indexed keywords

BLOOD VESSELS; DNA; ETHERS; ETHYLENE; ETHYLENE GLYCOL; GENES; HEART; POLYOLS;

AORTIC HEART VALVES; DEGRADATION EFFECT; ENDOGENOUS RETROVIRUS; EPOXY COMPOUND; ETHYLENE GLYCOL DIGLYCIDYL ETHERS; GLUTARALDEHYDES; HEART VALVES; PORCINE ENDOGENOUS RETROVIRUS; PORCINE HEART VALVE; REAL-TIME PCR;

POLYMERASE CHAIN REACTION;

CROSS LINKING REAGENT; EPOXIDE; ETOGLUCID; GENOMIC DNA; GLUTARALDEHYDE; VIRUS DNA; EPOXY RESIN; FIXATIVE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; QUETOL 651;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA VALVE; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; CONTROLLED STUDY; DNA CROSS LINKING; DNA DEGRADATION; DNA ISOLATION; ENDOGENOUS RETROVIRUS; GENE DOSAGE; NONHUMAN; PORCINE ADENOVIRUS; PORCINE ENDOGENOUS RETROVIRUS A; PORCINE ENDOGENOUS RETROVIRUS B; PORCINE ENDOGENOUS RETROVIRUS C; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS; TEMPERATURE; TISSUE FIXATION; ANIMAL; BIOPROSTHESIS; COMPARATIVE STUDY; DISEASE TRANSMISSION; DRUG EFFECT; GENETICS; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INFECTION; INSTRUMENTATION; ISOLATION AND PURIFICATION; PROSTHESIS; RETROVIRUS INFECTION; SWINE; TIME; VIROLOGY; ZOONOSIS;

ANIMALS; BIOPROSTHESIS; DNA, VIRAL; EPOXY RESINS; FIXATIVES; GLUTARAL; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; SWINE; TEMPERATURE; TIME FACTORS; TISSUE FIXATION; ZOONOSES;

EID: 84862268943     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000071     Document Type: Article

References (42)

1. Sung RS, Galloway J, Tuttle-Newhall JE, et al. Organ Donation and Utilization in the United States, 1997-2006. Am J Transplant. 2008; 8: 922-934.
2. Taniguchi S, Cooper DKC. Clinical xenotransplantation: past, present and future. Ann R Coll Surg Engl. 1997;79(1):13-19. Medline.
3. Cozzi E, Bosio E, Seveso M, Rubello D, Ancona E. Xenotransplantation as a model of integrated, multidisciplinary research. Organogenesis. 2009;5(1):288-296. Medline.
4. Shi M, Wang X, De Clercq E, Takao S, Baba M. Selective inhibition of porcine endogenous retrovirus (PERV) replication in human cells by acyclic nucleoside phosphonates. Antimicrob Agents Chemother. 2007;51(7):2600-2604. Medline. doi:10.1128/AAC.00212-07.
5. Smolenski RT, Khalpey Z, Osborne FN, et al. Species differences of endothelial extracellular nucleotide metabolism and its implications for xenotransplantation. Pharmacol Rep. 2006;58:118-125. Medline.
6. Garkavenko O, Croxson CM, Irgang M, Karlas A, Denner J, Elliott RB. Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation. J Clin Microbiol. 2004;42(11):5353-5356. Medline. doi:10.1128/ JCM.42.11.5353-5356.2004.
7. Liu Q, Liu Z, Dalakas E. Prevalence of porcine endogenous retrovirus in Chinese pig breeds and in patients treated with a porcine liver cell-based bioreactor. World J Gastroenterol. 2005;11(30):4727-4730. Medline.
8. Yoo D, Giulivi A. Xenotransplantation and the potential risk of xenogeneic transmission of porcine viruses. Can J Vet Res. 2000;64(4):193-203. Medline.
9. Zhong R, Platt JL. Current status of animal-to-human transplantation. Expert Opin Biol Ther. 2005;5(11):1415-1420. Medline. doi:10.1517/14712598.5.11.1415.
10. Bösch S, Arnauld C, Jestin A. Study of full-length porcine endogenous retrovirus genomes with envelope gene polymorphism in a specific-pathogen-free large white swine herd. J Virol. 2000;74(18):8575-8581. Medline. doi:10.1128/ JVI.74.18.8575-8581.2000.
11. Moon HJ, Kim HK, Park SJ, et al. Comparison of the age-related porcine endogenous retrovirus (PERV) expression using duplex RT-PCR. J Vet Sci. 2009;10(4):317-322. Medline. doi:10.4142/jvs.2009.10.4.317.
12. Moza AK, Mertsching H, Herden T, Bader A, Haverich A. Heart valves from pigs and the porcine endogenous retrovirus: experimental and clinical data to assess the probability of porcine endogenous retrovirus infection in human subjects. J Thorac Cardiovasc Surg. 2001;121(4):697-701. Medline. doi:10.1067/mtc.2001.112530.
13. Zilla P, Brink J, Human P, Bezuidenhout D. Prosthetic heart valves: catering for the few. Biomaterials. 2008;29(4):385-406. Medline. doi:10.1016/j.biomaterials.2007.09.033.
14. Vesely I. Heart valve tissue engineering. Circ Res. 2005; 97(8): 743-755. Medline. doi:10.1161/01.RES. 0000185326.04010.9f 15.
15. Manji RA, Zhu LF, Nijjar NK, et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation. 2006;114(4):318-327. Medline. doi:10.1161/CIRCULATIONAHA.105.549311.
16. Raghavan D, Shah SR, Vyavahare NR. Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves. J Biomed Mater Res B Appl Biomater. 2010;92(1):168-177. Medline. doi:10.1002/jbm.b.31503.
17. Vyavahare NR, Hirsch D, Lerner E, et al. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res. 1998;40(4):577-585. Medline. doi:10.1002/(SICI)1097-4636(19980615)40:4<577::AID-JBM9>3.0.CO;2-C
18. Connolly JM, Alferiev I, Kronsteiner A, et al. Ethanol inhibition of porcine bioprosthetic heart valve cusp calcification is enhanced by reduction with sodium borohydride. J Heart Valve Dis. 2004;13(3):487-493. Medline.
19. Chen W, Schoen FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation. 1994;90(1):323-329. Medline.
20. Myers DJ, Nakaya G, Girardot MN, et al. A comparison between glutaraldehyde and diepoxide-fixed stentless porcine aortic valves: biomechanical and mechanical characterization and resistance to mineralization. J Heart Valve Dis. 1995;4(Suppl 1):s98-s101. Medline.
21. Connolly JM, Alferiev I, Clark-Gruel JN, et al. Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance. Am J Pathol. 2005;166(1):1-13. Medline. doi:10.1016/S0002-9440(10)62227-4.
22. Zhuravleva IYu, Kuznetsov PV, Gantimurova IL, Barbarash LS. The use of diepoxy compound and derivatives in the preservation of heart valve. Biomaterial-Living System Interaction. 1994;2(1):11-19.
23. Okoshi T, Noishiki Y, Tomizava Y, et al. A new bioprosthetic cardiac valve with reduced calcification. ASAIO Trans. 1990;36(3):M411-M414. Medline.
24. Imamura E, Sawatani O, Koyanagi H, et al. Epoxy compounds as a new cross-linking agent for porcine aortic leaflets-subcutaneous implant studies in rats. J Card Surg. 1989;4(1):50-57. Medline. doi:10.1111/j.1540-8191.1989. tb00256.x.
25. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. Medline. doi:10.1093/ nar/16.3.1215.
26. Machnik G, Sypniewski D, Gałka S, et al. Changes of syncytin I expression level in HEK293 cells line after infection by porcine endogenous retroviruses (PERV). Scientific Review in Pharmacy. 2010;7(12):14-20.
27. Li Z, Ping Y, Shengfu L, et al. Variation of host cell tropism of porcine endogenous retroviruses expressed in Chinese Banna minipig inbred. Intervirology. 2006;49(4):185-191. Medline. doi:10.1159/000090787.
28. Denner J. Porcine endogenous retroviruses (PERVs) and xenotransplantation: screening for transmission in several clinical trials and in experimental models using non-human primates. Ann Transplant. 2003;8(3):39-48. Medline.
29. Moalic Y, Blanchard Y, Félix H, Jestin A. Porcine endogenous retrovirus integration sites in the human genome: features in common with those of murine leukemia virus. J Virol. 2006;80(22):10980-10988. Medline. doi:10.1128/JVI.00904-06.
30. Gu C, Wei X, Wang Y, et al. No infection with porcine endogenous retrovirus in recipients of acellular porcine aortic valves: a two-year study. Xenotransplantation. 2008;15(2):121-128. Medline. doi:10.1111/j.1399-3089.2008.00447.x
31. Prabha SM, Verghese S. Polymerase chain reaction in detection of porcine endogenous retrovirus (PERV) from porcine tissues. Indian J Microbiol. 2009;49(1):68-71. doi:10.1007/ s12088-009-0002-4.
32. Prabha S, Verghese S. Existence of proviral porcine endogenous retrovirus in fresh and decellularised porcine tissues. Indian J Med Microbiol. 2008;26(3):228-232. Medline. doi:10.4103/0255-0857.42032.
33. Sypniewski D, Machnik G, Mazurek U, et al. Distribution of porcine endogenous retroviruses (PERVs) DNA in organs of a domestic pig. Ann Transplant. 2005;10(2):46-51. Medline.
34. Harrison I, Takeuchi Y, Bartosch B, Stoye PJ. Determinants of high titer in recombinant porcine endogenous retrovirus es. J Virol. 2004;78(24):13871-13879. Medline. doi:10.1128/ JVI.78.24.13871-13879.2004.
35. Bartosch B, Stefanidis D, Myers R, Weiss R, Patience C, Takeuchi Y. Evidence and consequence of porcine endogenous retrovirus recombination. J Virol. 2004;78(24):13880-13890. Medline. doi:10.1128/JVI.78.24.13880-13890.2004.
36. Dieckhoff B, Kessler B, Jobst D, et al. Distribution and expression of porcine endogenous retroviruses in multitransgenic pigs generated for xenotransplantation. Xenotransplantation. 2009;16(2):64-73. Medline. doi:10.1111/ j.1399-3089.2009.00515.x
37. Argaw T, Ritzhaupt A, Wilson CA. Development of a realtime quantitative PCR assay for detection of porcine endogenous retrovirus. J Virol Methods. 2002;106(1):97-106. Medline. doi:10.1016/S0166-0934(02)00140-4.
38. Ota T, Taketani S, Iwai S, et al. Novel method of decellularization of porcine valves using polyethylene glycol and gamma irradiation. Ann Thorac Surg. 2007;83(4):1501-1507. Medline. doi:10.1016/j.athoracsur.2006.11.083.
39. Leyh RG, Wilhelmi M, Walles T, et al. Acellularized porcine heart valve scaffolds for heart valve tissue engineering and the risk of cross-species transmission of porcine endogenous retrovirus. J Thorac Cardiovasc Surg. 2003;126(4):1000-1004. Medline. doi:10.1016/S0022-5223(03)00353-2.
40. Shi M, Wang X, Clercq E, Takao S, Baba M. Selective inhibition of porcine endogenous retrovirus replication in human cells by acyclic nucleoside phosphonates. Antimicrob Agents Chemother. 2007;51(7):2600-2604. Medline. doi:10.1128/AAC.00212-07.
41. Dieckhoff B, Petersen B, Kues WA, Kurth R, Niemann H, Denner J. Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs. Xenotransplantation. 2008;15(1):36-45. Medline. doi:10.1111/j.1399-3089.2008.00442.x
42. Ramsoondar J, Vaught T, Ball S, et al. Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAs. Xenotransplantation. 2009;16(3):164-180. Medline. doi:10.1111/j.1399-3089.2009.00525.x